Clinical Trials Directory

Trials / Completed

CompletedNCT03478475

Vitamin D Supplementation and and Glycemic Indexes

Effect of Vitamin D Treatment on Glucose Homeostasis and Metabolism in Lebanese Older Adults: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
115 (actual)
Sponsor
Université d'Auvergne · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

Age affect insulin sensitivity and the metabolism, and vitamin D status was shown to have a correlation with markers of insulin resistance. That's why, we aimed in our trial to study the effect of vitamin D supplementation on glycemic markers and index of insulin resistance.

Detailed description

A low serum 25-hydroxyvitamin D \[(25(OH) D)\] concentration was shown to correlate with higher fasting blood glucose (FBG) and insulin levels. Since age affect insulin sensitivity and the metabolism, we aimed in this randomized controlled trial to investigate the effect of vitamin D supplementation on glucose homeostasis and index of insulin resistance in elderly subjects living in Beirut, Lebanon. Participants (n= 115) deficient in vitamin D were randomly divided into two groups, a group receiving 30,000 IU cholecalciferol/week for a period of 6 months, and a placebo group. The index of insulin resistance HOMA (homeostasis model assessment) was the primary outcome. Glucose homeostasis and metabolic markers were also measured at start of treatment and at 6 months.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcholecalciferol (Euro-Pharm International, Canada)
OTHERPlaceboPlacebo pill (microcrystalline cellulose 66.3%, starch 33.2%, magnesium stearate 0.5%)

Timeline

Start date
2015-07-02
Primary completion
2015-09-19
Completion
2015-09-19
First posted
2018-03-27
Last updated
2018-03-29

Source: ClinicalTrials.gov record NCT03478475. Inclusion in this directory is not an endorsement.